Nurse Practitioner, Adult Health · New York, NY
NPI
1609936046
Since 2006
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
530 First Ave, NYU Langone Medical Center
New York, NY, 10016
Phone (646) 501-0119
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,649
76 services
Medicare patients, 2024
61
Average age 82
Drug cost, 2024
$40.4M
2,129 prescriptions
Company payments, 2025
$4,032
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maureen C Geary was code 99214 (office e&m - established), 35 times for 33 patients. In total Maureen C Geary billed 76 services in 8 codes, and Medicare paid $5,649.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 35 | 33 | $91.64 | $3,207 |
| 99213 Office E&M - Established | Facility | 18 | 17 | $43.52 | $783 |
By year: 2022 $4,078 for 67 services; 2023 $3,336 for 59 services; 2024 $5,649 for 76 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maureen C Geary prescribed most often to Medicare patients was Vyndamax (Tafamidis), with 1,057 prescriptions and refills. In total Maureen C Geary wrote 2,129 Medicare prescriptions that cost $40.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vyndamax Tafamidis | 1,057 | 1,713 | 187 | $37.1M |
| Torsemide Generic | 128 | 336 | 48 | $6,616 |
| Eliquis Apixaban | 106 | 272 | 40 | $155K |
| Jardiance Empagliflozin | 99 | 259 | 36 | $148K |
| Atorvastatin Calcium Generic | 92 | 267 | 34 | $1,076 |
| Furosemide Generic | 75 | 208 | 33 | $501 |
| Eplerenone Generic | 61 | 161 | 25 | $5,193 |
| Amlodipine Besylate Generic | 49 | 134 | 21 | $372 |
| Spironolactone Generic | 45 | 129 | 17 | $574 |
| Metoprolol Succinate Generic | 33 | 99 | 14 | $249 |
| Rosuvastatin Calcium Generic | 32 | 94 | 12 | $542 |
| Vyndaqel Tafamidis Meglumine | 30 | 68 | 12 | $1.3M |
| Amiodarone Hcl Generic | 26 | 70 | 13 | $1,179 |
| Potassium Chloride Generic | 23 | 53 | Under 11 | $2,121 |
| Xarelto Rivaroxaban | 20 | 48 | Under 11 | $26K |
Brand drugs: 1,410 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maureen C Geary $4,032 ($4,032 in general payments such as food, travel and fees) from 8 companies. The largest payer was BridgeBio Pharma, Inc. with $3,586.
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. BBIO | 10 | $3,586 |
| Abbott Laboratories ABT | 4 | $156 |
| Alnylam Pharmaceuticals Inc. ALNY | 2 | $90.9 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $86.67 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $54.95 |
| Merck Sharp & Dohme LLC MRK | 1 | $22.49 |
| Pfizer Inc. PFE | 1 | $17.24 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $16.58 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.